Tenascin C-Guided Nanosystem for Precision Delivery of Obeticholic Acid in Liver Fibrosis Therapy
<b>Objective:</b> Liver fibrosis, a hallmark of chronic liver diseases, is characterized by excessive extracellular matrix (ECM) deposition and scar tissue formation. Current antifibrotic nanomedicines face significant limitations, including poor penetration into fibrotic tissue, rapid c...
Saved in:
Main Authors: | Yawen Wang, Lei Yang, Qing Xu, Taiyu Liu, Hongliang He, Lisha Liu, Lifang Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/32 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction
by: Pasquale Tondo, et al.
Published: (2025-01-01) -
Microfluidic Nanoparticle Separation for Precision Medicine
by: Zhenwei Lan, et al.
Published: (2025-01-01) -
Treatment patterns and clinical profile in progressive pulmonary fibrosis: a Japanese cross-sectional survey
by: Hidekata Yasuoka, et al.
Published: (2025-01-01) -
Preparation, characterisation, and in vitro cancer‐suppression function of RNA nanoparticles carrying miR‐301b‐3p Inhibitor
by: Junjie Zhao, et al.
Published: (2023-05-01) -
Updates in the management of connective tissue disease-associated interstitial lung disease
by: Chengappa Kavadichanda, et al.
Published: (2021-01-01)